PharMerica Co. (NYSE:PMC) CEO Gregory S. Weishar sold 521,089 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $29.25, for a total value of $15,241,853.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of PharMerica Co. (NYSE PMC) opened at $29.25 on Tuesday. PharMerica Co. has a 52-week low of $22.00 and a 52-week high of $29.50. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.79 and a current ratio of 2.58. The stock has a market capitalization of $910.27, a P/E ratio of 15.15, a price-to-earnings-growth ratio of 1.27 and a beta of 0.82.

PharMerica (NYSE:PMC) last issued its quarterly earnings data on Thursday, November 9th. The company reported $0.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.03). PharMerica had a net margin of 0.83% and a return on equity of 10.94%. The company had revenue of $595.10 million for the quarter, compared to analysts’ expectations of $596.80 million. equities research analysts predict that PharMerica Co. will post 1.92 EPS for the current year.

A number of equities research analysts recently commented on the company. Zacks Investment Research upgraded PharMerica from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a research report on Wednesday, September 27th. ValuEngine downgraded PharMerica from a “buy” rating to a “hold” rating in a research report on Friday, September 22nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $30.50.

A number of hedge funds have recently modified their holdings of the business. California Public Employees Retirement System raised its position in PharMerica by 5.6% during the third quarter. California Public Employees Retirement System now owns 97,587 shares of the company’s stock valued at $2,859,000 after purchasing an additional 5,187 shares during the period. Allianz Asset Management GmbH grew its stake in shares of PharMerica by 3,347.4% during the third quarter. Allianz Asset Management GmbH now owns 399,591 shares of the company’s stock valued at $11,708,000 after buying an additional 388,000 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of PharMerica by 1.5% during the third quarter. Schwab Charles Investment Management Inc. now owns 269,518 shares of the company’s stock valued at $7,897,000 after buying an additional 3,864 shares during the last quarter. WINTON GROUP Ltd bought a new position in shares of PharMerica during the third quarter valued at approximately $2,150,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of PharMerica during the third quarter valued at approximately $7,031,000. Institutional investors and hedge funds own 89.97% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “PharMerica Co. (PMC) CEO Gregory S. Weishar Sells 521,089 Shares of Stock” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/pharmerica-co-pmc-ceo-gregory-s-weishar-sells-521089-shares-of-stock/1758563.html.

About PharMerica

Insider Buying and Selling by Quarter for PharMerica (NYSE:PMC)

Receive News & Ratings for PharMerica Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica Co. and related companies with MarketBeat.com's FREE daily email newsletter.